Expert consensus panel (five psychiatrists) reviewing two network meta-analyses of FDA-approved adjunctive atypical antipsychotics for adults with major depressive disorder and inadequate antidepressant response; they judged the evidence broadly concordant but endorsed no agent.
Meta-analysis
Cutler et al. Adjunctive Atypical Antipsychotics in Major Depressive Disorder: A Network Meta-Analysis Perspective and Consensus Panel Discussion